Skip to main content

Front Row Advisors LLC

SEC CIK
0001729254
Latest filing
Aug 13, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
96
Value
$8.99K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of EW by Front Row Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202696$8.99K<0.1%00.0%UnchangedHolders
Q1 202696$7.69K<0.1%00.0%UnchangedHolders
Q4 202596$8.18K<0.1%00.0%UnchangedHolders
Q3 202596$7.47K<0.1%−48−33.3%ReducedHolders
Q2 2025144$11.3K<0.1%−96−40.0%ReducedHolders
Q1 2025240$17.4K<0.1%00.0%UnchangedHolders
Q4 2024240$17.8K<0.1%00.0%UnchangedHolders
Q3 2024240$15.8K<0.1%00.0%UnchangedHolders
Q2 2024240$22.2K<0.1%00.0%UnchangedHolders
Q1 2024240$22.9K<0.1%00.0%UnchangedHolders
Q4 2023240$18.3K<0.1%00.0%UnchangedHolders
Q3 2023240$16.6K<0.1%00.0%UnchangedHolders
Q2 2023240$23.0K<0.1%00.0%UnchangedHolders
Q1 2023240$20.0K<0.1%+240NewHolders
Q4 20220$00.0%−240−100.0%Sold outHolders
Q3 2022240$20.0K<0.1%00.0%UnchangedHolders
Q2 2022240$23.0K<0.1%00.0%UnchangedHolders
Q1 2022240$28.0K<0.1%00.0%UnchangedHolders
Q4 2021240$31.0K<0.1%00.0%UnchangedHolders
Q3 2021240$27.0K<0.1%00.0%UnchangedHolders
Q2 2021240$28.0K<0.1%00.0%UnchangedHolders
Q1 2021240$20.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.